The biological function of miR-128-2 in hepatocellular carcinoma and its molecular mechanism functioning

• Published in: Pathology, research and practice Vol. 254; p. 155178
• Main Authors: Jin, Jingzhe, Ren, Mingcheng
• Format: Journal Article
• Language: English
• Published: Germany Elsevier GmbH 01.02.2024
• Subjects: Diagnosis; HCC; MiR-128–2; MiR-128–2; HCC; Diagnosis
• ISSN: 0344-0338; 1618-0631; 1618-0631
• DOI: 10.1016/j.prp.2024.155178

Hepatocellular carcinoma (HCC) represents the major type of primary liver cancers, which is a most prevalent malignancy, as well as seriously threatens people's life and health. MiR-128–2 was reported to be associated with several human cancers, and is participated in the pathogenesis and development of cancers. Our research was performed to explore the expression profile and diagnostic significance of miR-128–2 in HCC. The serum miR-128–2 expression was measured in 130 HCC subjects and 118 healthy people using quantitative real-time polymerase chain reaction (qRT-PCR) assay. Chi-square (ÿ2) test was utilized to estimate the relationship of miR-128–2 level with clinicopathological characteristic. In addition, the diagnostic accuracy of miR-128–2 in HCC was estimated via receiver operating characteristic (ROC) curve analysis. Compared with healthy individuals, the level of miR-128–2 was obviously up-regulated in HCC cases (P < 0.01). And its level was closely related to AFP level (P = 0.013), TNM stage (P = 0.009) and differentiation (P = 0.036). Nevertheless, there was no obvious relationship with age, gender, tumor size, HBV status, ALT or metastasis (all P > 0.05). According to the ROC curve, serum miR-128–2 had a high value in discriminating HCC cases from control individuals, with a AUC value of 0.880 combing with the sensitivity of 79.2% and the specificity of 83.9%. The serum level of miR-128–2 in cases with HCC was obviously increased, which was related to the malignant progression of HCC. Due to the reasonable sensitivity and specificity, miR-128–2 might be as a new and effective marker for the diagnosis of HCC.